Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-CenterPing Wu,Wei Ling,Chengwei Luo,Xiaomei Chen,Lisi Huang,Jinghua Wang,Peilong Lai,Suijing Wu,Xin Du,Jianyu WengBLOOD(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要